NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
57894-061-03 | 57894-061 | HUMAN PRESCRIPTION DRUG | STELARA | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20090925 | N/A | BLA | BLA125261 | Janssen Biotech, Inc. | USTEKINUMAB | 90 mg/mL | 1 SYRINGE in 1 CARTON (57894-061-03) / 1 mL in 1 SYRINGE |
57894-061-04 | 57894-061 | HUMAN PRESCRIPTION DRUG | STELARA | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20090925 | N/A | BLA | BLA125261 | Janssen Biotech, Inc. | USTEKINUMAB | 90 mg/mL | 1 SYRINGE in 1 CARTON (57894-061-04) / 1 mL in 1 SYRINGE |
57894-060-02 | 57894-060 | HUMAN PRESCRIPTION DRUG | STELARA | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20090925 | N/A | BLA | BLA125261 | Janssen Biotech, Inc. | USTEKINUMAB | 45 mg/.5mL | 1 VIAL, SINGLE-USE in 1 CARTON (57894-060-02) / .5 mL in 1 VIAL, SINGLE-USE |
57894-060-03 | 57894-060 | HUMAN PRESCRIPTION DRUG | STELARA | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20090925 | N/A | BLA | BLA125261 | Janssen Biotech, Inc. | USTEKINUMAB | 45 mg/.5mL | 1 SYRINGE in 1 CARTON (57894-060-03) / .5 mL in 1 SYRINGE |
57894-060-04 | 57894-060 | HUMAN PRESCRIPTION DRUG | STELARA | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20090925 | N/A | BLA | BLA125261 | Janssen Biotech, Inc. | USTEKINUMAB | 45 mg/.5mL | 1 SYRINGE in 1 CARTON (57894-060-04) / .5 mL in 1 SYRINGE |